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Objective. To determine critical issues for future awareness programmes on peripheral arterial disease (PAD).
Design. National Dutch survey.
Materials and methods. A representative sample of 1294 members of the general population, and 281 patients with PAD
from the Capi@home database were administered a questionnaire concerning awareness of PAD.
Results. The response rate was 81% for the general population and 78% for patients with PAD. The familiarity with PAD
terminology and symptoms amongst the general population was low. Few patients (20%) were aware that PAD was a disease
of arteries. Amongst both the general population and the patient populations, PAD risk factors identification was low:
hypertension (4% versus 0%); hypercholesterolaemia (9% versus 12%), diabetes (2% versus 8%), and smoking (27% versus
52%). Knowledge was moderate in both populations about treatment with exercise, but low for smoking cessation. The
general population was unaware of the central role of general practitioners in the treatment of PAD.
Conclusions. The awareness of symptoms, risk factors, and treatment options for PAD is low. Both population and patients
needed only minimal information to relate PAD to other atherosclerotic diseases. Based on the results of this survey the
Dutch Platform of Peripheral Arterial Disease together with the Dutch Heart Foundation are initiating the first awareness
campaign on atherosclerosis.
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Introduction
In 1998 the Dutch Heart Foundation, in collaboration
with the Dutch Society for Vascular Surgery and the
Dutch Society for Vascular Patients, published a report
called ‘Vaatpatie¨nten in beeld’ (Vascular patients in the
picture).1 The report painted a picture of the situation
of vascular care in the Netherlands in 1998. With respect
to peripheral arterial disease (PAD), the report contained
recommendations on making improvements in primary
and secondary risk factor management, increasing
general practitioner and vascular specialist care, and
on developing an exercise therapy infrastructure.
Some of these recommendations have recently been
implemented, whilst others are currently being devel-
oped. One of the report’s main conclusions was that
the awareness of PAD (e.g. its cause, prevention and
treatment) amongst the general population as well as
amongst patients with PAD should be increased.1 The
combined prevalence of symptomatic and asympto-
matic PAD in the population of 55 years and over in
primary care settings in the UK, USA and the Nether-
lands is 18 – 23%.2 – 4 The overall ageing of the
population, due to the arrival of the ‘baby boom
generation’, increases the percentage of patients with
PAD. Despite these increases, no actions have so far
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been initiated to start an awareness or educational
programme on PAD.
Patients with symptomatic PAD have at least a 30%
risk of death within 5 years rising to almost 50% within
10 years, resulting primarily from myocardial infarc-
tion or stroke. Together these are responsible for 60
and 12% of total mortality, respectively.5 These risks
are highest for patients requiring surgery, but even
individuals with an ankle-brachial index below 0.9,
who do not seek medical care, have a 2–5-fold
increased risk of fatal or non-fatal cardiovascular
events compared to the normal population.5 – 7 The
development and progression of PAD is strongly
influenced by vascular risk factor management and
life style changes. Risk factor management in primary
care settings focuses mainly on the detection and
treatment of diabetes, hypertension and hyper-
cholesterolaemia. Lifestyle changes consist of smoking
cessation, as the single most powerful risk factor
associated with the aetiology and clinical progression
of PAD.8,9 Exercise therapy is the primary conservative
treatment when walking is impaired.10,11
Early identification of the disease could lead to
earlier vascular risk-factor modification and result in a
subsequent decrease in progression of PAD as well as a
reduction in cardiovascular events.12 Early detection
depends not only on physician awareness, but also on
the public being aware of symptoms and vascular risk
factors.13,14
The aim of this study was to assess current awareness
and knowledge of PAD in the general population and
amongst patients with PAD by means of two surveys.
Methods
Two surveys were performed by the Dutch Institute
for Public Opinion and Market Research (NIPO) in
2003, one carried out amongst the general population
and one amongst patients with known PAD. Both
surveys covered topics on general knowledge of PAD
terminology and symptoms, risk factors, and treat-
ment options by personal efforts and in a medical
setting (Appendix A and B). Preliminary versions of
the surveys were piloted in the respective populations
in order to assess their comprehensibility (cognitive
debriefing) and adapted when appropriate. The pilot
data have not been used in the final data collection.
Population
A representative sample of 1294 members of the
general population of 18 years or older and 281
patients with PAD above the age of 35 years in the
Netherlands was derived from the Capi@home
database. The participants gave informed consent for
the anonymous use of the data. For inclusion in the
patient population, patients had to have been diag-
nosed with PAD by a general practitioner or vascular
surgeon.
The Capi@home database contains extensive infor-
mation on general topics as well as on diseases of more
than 100,000 inhabitants in the Netherlands and was
used for surveys on public opinion. The survey
participants received the digitally transmitted ques-
tionnaire on a personal computer at home, which they
completed and returned via a direct modem. In the
Netherlands, 79% of all households have a personal
computer with internet access.
In order to obtain a representative sample from both
populations, demographic frequency matching was
carried out in respect of the following variables: age,
sex, income, family size, ethnic background, education
and postcode. The database is over-sampled in the
categories of respondents with low personal computer
ownership, particularly amongst older people and the
less well educated. However, the size of the database
enabled samples to be drawn, which were representa-
tive of both populations. The participants gave
informed consent.
Analysis
The sample size was calculated on the basis of the
maximum width of the 95% confidence interval
around the observed point estimates. In order to
obtain a width of less than 7.5% (one-sided margin of
error 3.75%) for the estimates of the general popu-
lation, at least 750 valid responses would be required
and likewise, 180 from the patient population to obtain
a width of less than 15% (one-sided margin of error
7.5%). Hence for sake of clarity 95% confidence
intervals are not described further. Differences
between groups were analysed with a chi-square test
using SPSS version 11.0.
Results
Population
The response rate for the 1294 members of the general
population was 81% and for the 281 patients with
PAD, 78%. This resulted in 1048 and 219 valid
questionnaires, respectively. The demographic charac-
teristics of both populations are presented in Table 1.
Current PAD Awareness in General Population Patients 623
Eur J Vasc Endovasc Surg Vol 27, June 2004
Demographic information on non-respondents was
not available. As expected, the majority of patients
with PAD were over 55 years of age and had stage II
PAD according to Fontaine (Rutherford grade I).
General knowledge about PAD terminology and symptoms
in the general population
Members of the general population were asked if they
were familiar with the various terms for PAD. The
layman’s term in Dutch, ‘etalage benen’ (literally
‘window-shopping legs’), was recognised most fre-
quently (by 56%). Fifteen percent had heard of
‘peripheral arterial disease’ and 5% was familiar
with the term ‘intermittent claudication’. This famili-
arity was higher among women (‘window-shopping
legs’ 67%; P , 0:0001) and people over 55 years of age
(‘window-shopping legs’ 72%; P , 0:0001). In the
general population, 22% knew a relative or friend
with PAD. When asked if they could identify one or
more symptoms of PAD, 16% answered pain in the
legs that subsides during rest (23% when a relative or
friend had PAD, compared to 13% in the remainder;
P , 0:0001) and 21% pain during walking. The sources
for additional information on PAD are presented in
Table 2. The difference between generations with
respect to the use of internet was statistically signifi-
cant ðP , 0:0001Þ; but even amongst elderly users, the
use of internet outweighed medical books as source of
information.
General knowledge about PAD terminology and symptoms
in the patient population
Of the patients, 21% were aware that PAD concerns the
arteries, 25% were of the opinion that the veins and the
arteries were diseased. Eleven percent considered it a
venous disease, and 43% did not know the localisation
of PAD. Thirty percent of patients searched for
additional information on PAD. These sources are
depicted in Table 2.
Knowledge of risk factors in the general population
When the general population was asked to classify
PAD, ranging from an innocent condition to a very
serious condition, 25% classified PAD as a relatively
innocent condition, 61% as relatively serious, 5% as
very serious, and 9% did not know how to classify
PAD at all. The aetiology of PAD was briefly explained
as: ‘a vascular problem causing an insufficient blood
supply to the legs resulting in pain in one or both leg(s)
during exercise which subsides during rest’. After this
explanation the general population was asked if there
might be an association between PAD and the
development of systemic cardiovascular diseases.
The majority (74%) assumed that there was an
association between PAD and an increasing likelihood
of developing cardiovascular diseases (females 80%;
males 68%; P: 0.04). The risk factors for developing
PAD that were mentioned spontaneously are detailed
in Table 3.
Knowledge of risk factors in patients with PAD
After the explanation of the aetiology of PAD, the
majority (77%) were of the opinion that an association
did exist between PAD and an increasing risk of
developing cardiovascular complications (females
Table 1. Demographic characteristics of the general population
and patients with PAD
General population Patients with PAD
Sex
Male 514 (49%) 117 (53%)
Female 534 (51%) 102 (47%)
Age distribution (years)
18–34 332 (32%)
35–44 405 (39%) 15 (7%)
45–54 42 (19%)
55–64 311 (30%) 51 (23%)
. 64 111 (51%)
Time since diagnosis (years)
. 5 100 (46%)
1–5 86 (39%)
1– 12 17 (8%)
1–6 (m) 16 (8%)
Walking distance (m)
. 100 156 (71%)
100–30 50 (23%)
, 30 14 (6%)
Table 2. Reference sources for additional information on PAD
General population Patients with PAD
Internet 701 (67%) 29 (44%)
18–34 years .55 years
79%* 50%*
Leaflet 476 (45%) 16 (24%)
Medical books 327 (31%)
18–34 years .55 years 2 (3%)
18%* 35%*
Doctor 28 (3%) 19 (30%)
Family/friend 26 (2%) 0
Patients association 24 (2%) 1 (1%)
Media 18 (2%) 4 (6%)
Unknown 68 (6%) 5 (7%)
*P: ,0.05.
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72%; males 81%; P , 0:0001). The results of the
question, ‘Could you name possible risk factors that
increases the risk of developing PAD?’, are summar-
ised in Table 3. A significant difference was present in
favour of the patients’ knowledge of risk factors
compared to the general population (x2: 138.1;
P , 0:0001).
Medical advice and treatment in the general population
If suffering pain on walking which subsides when
resting, 23% of the general population said they would
visit a physician immediately, and a further 75%
would go later, if the complaints persisted. When
asked about which medical discipline would be
primarily responsible for treatment of PAD, 27%
were of the opinion that a vascular surgeon would
be responsible, 14% an internal medicine specialist,
12% a cardiologist and 31% said that they did not
know. When requested to list possible treatment
options for PAD, 29% mentioned medication, 17%
surgery, 14% physical exercise, 9% angioplasty and 4%
smoking cessation. Over one third (37%) were
unfamiliar with any treatment. Life-style changes
reported that could be undertaken to improve PAD,
are depicted in Table 4. Increasing the daily amount
of physical exercise was mentioned relatively often
(47%), while smoking cessation received little atten-
tion (18%).
Medical advice and treatment in patients with PAD
Of the patients with PAD, 56% smoked at the time of
onset of the complaint. Of these patients who smoked
at the onset of complaint, 45% continued smoking
(males 33% and females 64%; P ¼ 0:01), and 48% had
quit smoking, but had smoked in the past 10 years
(males 59% and females 33%; P ¼ 0:001). Patients
reported that the general practitioner had measured
their blood pressure in 95%, cholesterol levels in 77%,
and fasting glucose levels in 64%. After the onset of
complaints, 34% of the patients reported having
consulted a physician within 6 months. At the time
of the interview, 50% of the patients with PAD were
seeing a vascular specialist, 27% were receiving
treatment from their general practitioner and 20%
were not seeing a physician any more. Of the patients
receiving treatment from a vascular specialist or
general practitioner, 33% were also seeing a cardiolo-
gist (males 47% and females 16%; P , 0:0001) and a
further 15% a neurologist. Patients reported signifi-
cantly more personal measures that could be under-
taken to improve PAD (x2: 35.5; P , 0:0001), compared
to the general population (Table 4).
Discussion
General knowledge on PAD terminology, symptoms and
risk factors
Familiarity with the terminology regarding PAD or
intermittent claudication in the general population is
Table 3. PAD risk factor recognition
General population Patients with PAD Patients reported personal risk factors
Smoking 279 (27%) 114 (52%) 74 (34%)
High cholesterol 89 (9%) 26 (12%) 19 (9%)
55–64 years .65 years
22%* 2%*
Hypertension 41 (4%) 0 0
Diabetes 24 (2%) 18 (8%) 14 (6%)
Increasing age 38 (4%) 9 (4%) 7 (3%)
Scarce physical exercise 293 (28%) 49 (23%) 15 (7%)
Male Female
34%* 9%*
Runs in the family 82 (8%) 33 (15%) 29 (13%)
Unknown 218 (21%) 23 (11%) 29 (13%)
*P: ,0.05.
Table 4. Treatment options endorsed by personal efforts
General population Patients with PAD
Exercise 478 (47%) 105 (48%)
Diet 331 (32%) 69 (32%)
Stop smoking 184 (18%) 66 (30%)
Medication 37 (4%) 27 (12%)
Life style 181 (18%) 28 (13%)
Unknown 259 (25%) 24 (11%)
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low. The familiarity increased if there was a friend or
relative with PAD. Similar increases in awareness have
been described for relatives of patients with diabetes,
but in comparison, PAD-related awareness is much
lower.15 Risk factors for PAD risk factors were
relatively unrecognised in both populations. Female
members of the general population were more aware
of risk factors for developing PAD than their male
counterparts. This was reversed in the patient popu-
lation, suggesting that male patients received or
perceived more information.
Medical advice and treatment
The general practitioner was not identified by the
general population as the central physician for
managing patients with PAD. This central role
should be emphasised in future awareness cam-
paigns. There was a large difference in number of
visits to a cardiologist between male and female
patients. This difference could be explained by the
more progressive PAD in men, but could also
suggest a possible under-treatment of women.16
The relatively low prevalence of a smoking history
in this survey, which in large population studies is
between 80 and 90%, could be explained partially
by the patients’ avoidance of socially less accep-
table responses.17,18 The relatively large number of
responses relating to the improvement of diet and
general lifestyle appear to be influenced by the
modern ‘health cult’.
Limitations of this survey
The survey results may be biased by personal interests
of the respondents. However, the high response-rate
would suggest that this potential bias is limited. If a
respondent bias exists, this would imply that actual
knowledge on PAD is even worse than this survey
indicates. The methodology of the survey, based on the
CAPI@home server, might account for the relatively
high percentage that utilises the internet as the
disease-related information resource. On the other
hand the majority (79%) of the Dutch households own
a personal computer with internet access, and this will
continue to rise.
Awareness
Patient delay in response to symptoms, as a result of
not recognising their importance, has been reported
in patients with heart attack and stroke.19,20 Only
one third of the patients with PAD seek medical care,
with a substantial delay after the start of symptoms;
resulting in a negative impact on the time of onset of
treatment and vascular risk factor management.6
This delay in treatment increases the risk of
cardiovascular events and allows more rapid pro-
gression of PAD.12
The low familiarity of PAD and accompanying
risk factors we observed in the Netherlands is
concerning, and worse than internationally
reported data.16 Community education in the
United States and Europe on improving awareness
and risk factor recognition has been shown to be
effective, with educational programmes on heart
attack, high blood pressure, cholesterol, PAD and
stroke.21 – 25 Data on the effects of community
educational programmes on clinical endpoints are
meagre and inconclusive. Programmes on increas-
ing the adherence to medication in patients with
hypertension and decreasing the dietary intake of
saturated fat have shown positive results, but have
failed to impact on the treatment of high choles-
terol and smoking.22 – 24 Despite these results, the
costs of community educational programmes have
been shown to outweigh the direct and indirect
financial burden of these diseases on the national
healthcare budget.23 Unfortunately only isolated
campaigns with respect to stopping smoking,
eating healthily, and keeping fit have already
been initiated in the Netherlands. In our survey,
it appears that PAD is easily explained as an
element of systemic atherosclerosis. Future aware-
ness campaigns should take advantage of this
knowledge and not be limited by different vascular
specialists, and cross speciality boundaries to cover
the full spectrum of atherosclerotic disorders.
Conclusions
The results of this survey indicate that in the
general population and in patients with PAD, the
general knowledge of PAD terminology, symptoms,
risk factors, and treatment options by behaviour and
lifestyle modification or medical treatment is sub-
optimal. Community education on improving
awareness and risk factor recognition has been
shown to be effective, but studies of the effects of
community education on clinical endpoints are
needed.
Based on the results of this survey the Dutch
Platform of Peripheral Arterial Disease together with
the Dutch Heart Foundation are initiating the first
awareness campaign, focussing on symptoms, risk
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factors, life style changes, and treatment options, for
atherosclerosis.
Appendix A. Abbreviated questionnaire for
general population; PAD: peripheral arterial
disease, IC: intermittent claudication, WSL:
window shopping legs
1. Have you ever heard or read anything about
PAD?
2. Have you ever heard or read anything about IC?
3. Have you ever heard or read anything about WSL?
4. Do you know anyone with PAD, IC, or WSL?
a. Yes (! 5)
b. No (! 6)





d. Someone else (colleague etc.)
6. What do you think when you hear the term PAD?
a. A very innocent condition
b. A relatively innocent condition
c. A relatively serious condition
d. A very serious condition
e. I do not know
7. To what extent do you think that the assumption
that the presence of vascular problems in the legs
gives a higher risk of developing vascular pro-
blems in the heart and head is correct?
a. I agree
b. I disagree
c. I completely disagree
d. I do not know
8. What kind of physical complaints in your opinion
are associated PAD or IC?
9. Which medical profession do you think is respon-
sible for treating PAD?
10. What would you do if you regularly felt pain in
your legs whilst walking and which subsided
when you rested?
11. At what point would you consult a physician if
you felt this pain in your legs?
12. Would you consider a referral by your general




d. Not important at all
e. I do not know
13. Which factors do you think increase the likelihood
of developing PAD?
14. In what way do you think PAD or IC can be
treated?
15. What could you personally do to reduce the
complaints associated with PAD?
16. Where would you seek out information on PAD?
Appendix B. Abbreviated questionnaire for
patients with PAD; PAD: peripheral arterial disease
1. How long have you been diagnosed with PAD?
2. How long did you wait to visit your general
practitioner after you first experienced PAD
complaints?




c. Arteries and veins
d. I do not know
4. Which risk factors do you think increase the
likelihood of developing PAD?
5. Which risk factors do you yourself have in the
development or deterioration of PAD?
6. What might you do personally to reduce the
complaints of PAD?
7. To what extent do you think that the assumption
that the presence of vascular problems in the legs
leads to a higher risk of developing vascular
problems in the heart and head is correct?
a. I agree
b. I disagree
c. I completely disagree
d. I do not know
8. Did you smoke at the moment you developed PAD
complaints?
a. Yes (! 9)
b. No (! 10)
9. Did you give up smoking after you developed
PAD?
10. Do you currently smoke or have you smoked in
the past 10 years?
a. I smoke
b. I have smoked in the past 10 years
c. I have smoked, but stopped .10 years ago
11. Who at the moment is your PAD physician?
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12. Which of the following items have been measured




d. None of the above
13. Has your ankle-brachial index ever been
measured?
14. Has your general practitioner spoken to you about
exercise therapy?
a. Yes (! 15)
b. No (! 16)
15. What has your general practitioner advised you to
do?
a. To walk more
b. To walk more and he/she also gave me an
additional brochure entitled ‘exercise therapy’
c. Referred me to a physiotherapist for exercise
therapy
d.I do not know
16. Has any physician ever given you antiplatelet
medication?
a. Yes (! 17)
b. No (! 18)
17. Which medical profession has prescribed this
medication?
18. How many metres are you able to walk before you
have to stop due to pain in your legs?
19. Have you even been operated on the arteries in
your legs?
20. Are you seeing a cardiologist for problems
associated with the arteries in your heart?
21. Are you visiting a neurologist for problems
associated with the arteries in your head?
22. Have you ever sought out additional information
on PAD?
a. Yes (! 23)
b. No
23. Where did you find this information?
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